pharma · Breast Cancer
MYLAN PHARMACEUTICALS PRIVATE
Mylan IRE Healthcare Limited
Mylan IRE Healthcare is a pharma organization headquartered in GB. Primary therapeutic focus areas include Breast Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this enti
Mumbai, IN HQ
255 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Employees
- 255
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Trastuzumab
Phase 3 · mab · Breast Cancer
Trastuzumab for Breast Cancer is a Phase 3 program (mab) at Mylan IRE Healthcare Limited with 1 ClinicalTrials.gov record(s).
Internal code MYL-Her 3001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Mylan IRE Healthcare Limited
- Phase
- Phase 3
- Modality
- mab
- Indication
- Breast Cancer
- Status
- completed
- Trials
- 1